The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Warit Ruanglertboon
Michael J. Sorich
Jessica M. Logan
Andrew Rowland
Ashley M. Hopkins
机构：
[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health
[2] University of South Australia,Mechanisms in Cell Biology and Disease Research Group, Clinical and Health Sciences, Cancer Research Institute
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Sorafenib; Proton pump inhibitors; Prediction; Survival outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2693 / 2697
页数：4
相关论文
共 50 条
  • [21] Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients
    Warit Ruanglertboon
    Michael J. Sorich
    Andrew Rowland
    Ashley M. Hopkins
    International Journal of Clinical Oncology, 2020, 25 : 1672 - 1677
  • [22] Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
    Lalani, Aly-Khan A.
    McKay, Rana R.
    Lin, Xun
    Simantov, Ronit
    Kaymakcalan, Marina D.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : 724 - 732
  • [23] Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients
    Ruanglertboon, Warit
    Sorich, Michael J.
    Rowland, Andrew
    Hopkins, Ashley M.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1672 - 1677
  • [24] Letter: proton pump inhibitors and the risk of hepatocellular carcinoma
    Ponzetto, Antonio
    Figura, Natale
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1164 - 1165
  • [25] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [26] The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Chen, Lufeng
    Su, Hongying
    Shao, Haibo
    Xu, Ke
    Liang, Songnian
    Liu, Ling
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 802 - 808
  • [27] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [28] Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Arizumi, Tadaaki
    Ueshirna, Kazuomi
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Mashiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 705 - 710
  • [29] Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis of SEER-Medicare Database
    Parikh, Neehar D.
    Marshall, Vincent D.
    Nathan, Hari
    Balkrishnan, Rajesh
    Shahinian, Vahakn
    HEPATOLOGY, 2015, 62 : 409A - 410A
  • [30] Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study
    Shou-Sheng Chu
    Yu-Hsuan Kuo
    Wen-Shan Liu
    Shih-Chang Wang
    Chung-Han Ho
    Yi-Chen Chen
    Ching-Chieh Yang
    Hung-Chang Wu
    Scientific Reports, 11
12345